Menu
Mobile menu

Randy Gregg, PhD

Randy Gregg, PhD

Associate Professor for Microbiology and Immunology
Campus: 
Carolinas Campus
Office: 

Magnolia Research Center

Department/Discipline: 
Phone: 
864-327-9816
Email: 
rgregg [at] carolinas.vcom.edu
Curriculum Vitae: 

Current Research Projects

  • Antigen presentation and immune cell viability in simulated microgravity
  • Effect of Ebola virus proteins, secreted glycoprotein and viral protein 40, upon natural killer cell function
  • Effects of simulated microgravity upon human pancreatic cancer cell growth and resistance to natural killer cell cytotoxicity
  • Efficacy of abdominal lymphatic pump technique in enhancing CD8+ T cell responses and adoptive cell therapy for cancer

Publications

Year Published Faculty Citation PMID
2018

Bradley JH, Harrison A, Corey A, Gentry N, Gregg RK. Ebola virus secreted glycoprotein decreases the anti-viral immunity of macrophages in early inflammatory responses. Cell Immunol. 2018 Feb;324:24-32. PMID: 29195741.

29195741
2017

Bradley JH, Stein R, Randolph B, Molina E, Arnold JP, Gregg RK. T cell resistance to activation by dendritic cells requires long-term culture in simulated microgravity. Life Sci Space Res (Amst). 2017 Nov;15:55-61. PMID: 29198314.

29198314
2014

Gregg RK. Immunology Overview (9), Innate and Adaptive Immunity (10), Major Histocompatibility Complex (11), Immunoglobulins (12), Complement System (13) and T Cell and B Cell Development, Receptors and Effector Cells (14) In Microbiology and Immunology - An Illustrated Review, 1st ed.; Sr. ed. Avalon Garcia. Thieme Publishers, New York, NY; 2014 Oct. 

2013

Gregg RK. Streptococci (16), Staphylococci (17) and Bacilli (18). In Microbiology and Immunology - An Illustrated Review, 1st ed.  Sr. ed. Avalon Garcia. Thieme Publishers, New York, NY; 2013 Oct. 

2013

Zaghouani H, Gregg RK. Method for endocytic presentation of an immunosuppressive for the treatment of type I diabetes. United States Patent 8,609,091. 17 December 2013.

2013

Zaghouani H, Gregg RK. Methods and compositions for preventing the onset of type I diabetes. United States Patent 8,603,471. 10 December 2013.

2012

Curd LM, Favors SE, Gregg RK. Pro-tumour activity of interleukin-22 in HPAFII human pancreatic cancer cells. Clin Exp Immunol. 2012 May; 168(2):192-9. PMID: 22471280.

22471280
2012

Favors SE, Curd LM, Gregg RK. Use of the anti-inflammatory cytokine interleukin-11 to reverse HIV-1gp120 repression of a natural killer cell line. Cell Immunol. 2012 Mar-Apr; 276(1-2):1-5. PMID: 22727646.

22727646